DILIC
AERI

Dai-ichi Life Insurance Company’s Aerie Pharmaceuticals AERI Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-22,792
Closed -$863K – 573
2016
Q4 		$863K Buy
+22,792
New +$862K 0.03% 417

Other funds holding AERI

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dai-ichi Life Insurance Company's AERI Position: Q1 2017 in Review

Dai-ichi Life Insurance Company sold out of Aerie Pharmaceuticals (AERI) in Q1 2017, closing a stake of 22,792 shares — an estimated $863K sold.

Dai-ichi Life Insurance Company first reported a position in AERI in Q4 2016 and held it in 1 quarter. The position peaked at $863K in Q4 2016. 159 funds tracked by Wall St. Rank hold AERI as of Q1 2017.

  • Dai-ichi Life Insurance Company reported no remaining Aerie Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Dai-ichi Life Insurance Company sold 22,792 Aerie Pharmaceuticals shares in Q1 2017, an estimated $863K.
  • Dai-ichi Life Insurance Company first reported a position in Aerie Pharmaceuticals in Q4 2016 and held it in 1 quarter.
  • Dai-ichi Life Insurance Company's Aerie Pharmaceuticals position peaked at $863K in Q4 2016.
  • 159 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2017.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2017, filed 10 May 2017.